Pure Global
South Korea MFDS registration In vitro water 22-182

Cardiovascular and Central Nervous System Treatment Drug Concentration Surveillance Test Reagent

KO: 심혈관및중추신경계치료약물농도감시검사시약
South Korea flagSouth Korea·Unknown·Dong-A Chammed Co., Ltd.·Approved Aug 22, 2022
Basic information
Item Serial Number
2022004286
License Number
In vitro water 22-182
체외수허22-182호
Classification Number
K06010.01
Device Class (Risk Classification)
Unknown
Classification Name
Cardiovascular and Central Nervous System Treatment Drug Concentration Surveillance Test Reagent
심혈관및중추신경계치료약물농도감시검사시약
Official English Name
IVD reagents for Cardiovascular, central nervous system TDM tests
Company information
Entity Name (Company)
Dong-A Chammed Co., Ltd.
동아참메드 주식회사
Category
In vitro diagnostic import business
체외진단수입업
Business License Number
체외 제 561 호
Important dates & status
Item Approval Date
Aug 22, 2022
Business Permit Date
May 16, 2005
Expiration Period
2022-08-22 ~ 2027-08-21
Model information
Model Name
MGS QMS Everolimus
About this record

This Unknown medical device is registered with South Korea's Ministry of Food and Drug Safety (MFDS / 식품의약품안전처) under license number In vitro water 22-182. Approved on Aug 22, 2022. Registered by Dong-A Chammed Co., Ltd..

Pure Global AI provides free access to comprehensive South Korea MFDS registration data, helping global MedTech companies analyze market presence and regulatory compliance for medical devices in South Korea.

Free DatabasePowered by Pure Global AIMFDS Official DataUnknown